In clinical trials: Semaglutide: Approximately 7% discontinued due to adverse events Tirzepatide: Approximately 4-7% discontinued due to adverse events (dose dependent) Retatrutide: Approximately 6-10% discontinued due to adverse events (dose dependent) These rates are relatively close, suggesting that despite the differences in mechanism and side effect profiles, all three medications are tolerable for the vast majority of people who start them
6 BatemanD
Understanding Glutathione: The Master Antioxidant Glutathione is often called the "master antioxidant" because it is found in nearly every cell in the human body
Altogether, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, toxicity profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities
The same paper reported no measured changes in FSH, LH, prolactin, or TSH for the secretagogues tested
[5] An empirical diagnosis of pyroglutamic acidosis can be made when the urine organic acid measurement is not readily available